Protective effects of Prussian blue nanozyme against sepsis-induced acute lung injury by activating HO-1

Sepsis is a life-threatening condition involving dysfunctional organ responses stemming from dysregulated host immune reactions to various infections. The lungs are most prone to failure during sepsis, resulting in acute lung injury (ALI). ALI is associated with oxidative stress and inflammation, and current therapeutic strategies are limited. To develop a more specific treatment, this study aimed to synthesise Prussian blue nanozyme (PBzyme), which can reduce oxidative stress and inflammation, to alleviate ALI. PBzyme with good biosafety was synthesised using a modified hydrothermal method. PBzyme was revealed to be an activator of haem oxygenase-1 (HO -1), improving survival rate and ameliorating lung injury in mice. Zinc protoporphyrin, an inhibitor of HO -1, inhibited the prophylactic therapeutic efficacy of PBzyme on ALI, and affected the nuclear factor-kappa B signaling pathway and activity of HO -1. This study demonstrates that PBzyme can alleviate oxidative stress and inflammation through HO -1 and has a prophylactic therapeutic effect on ALI. This provides a new strategy and direction for the clinical treatment of sepsis-induced ALI.